THC Biomed Intl Ltd.
THCBF · OTC
7/31/2022 | 7/31/2021 | 7/31/2020 | 7/31/2019 | |
|---|---|---|---|---|
| Market Cap | $9 | $17 | $31 | $25 |
| - Cash | $0 | $0 | $1 | $1 |
| + Debt | $2 | $3 | $3 | $3 |
| Enterprise Value | $11 | $20 | $33 | $27 |
| Revenue | $2 | $4 | $4 | $1 |
| % Growth | -35.1% | -9.7% | 180.5% | – |
| Gross Profit | -$1 | -$3 | $3 | $2 |
| % Margin | -42% | -84.1% | 77.6% | 100.9% |
| EBITDA | -$2 | -$5 | $1 | -$12 |
| % Margin | -66.8% | -131.3% | 29% | -805.4% |
| Net Income | -$3 | -$6 | -$0 | -$13 |
| % Margin | -125.2% | -168.5% | -3.9% | -852.5% |
| EPS Diluted | -0.019 | -0.039 | -0.001 | -0.096 |
| % Growth | 51.9% | -3,790% | 99% | – |
| Operating Cash Flow | -$2 | -$1 | $0 | -$2 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$7 |
| Free Cash Flow | -$2 | -$1 | -$1 | -$9 |